Daily low-dose aspirin and incident type 2 diabetes in community-dwelling healthy older adults: a post-hoc analysis of efficacy and safety in the ASPREE randomised placebo-controlled trial
Sophia Zoungas, Zhen Zhou, Alice Owen, Andrea J. Curtis, Sara Espinoza, Michael E. Ernst, Robyn L. Woods, Suzanne G. Orchard, John J. McNeil, Anne M. Murray, Mark Nelson, Christopher M. Reid, Joanne Ryan, Rory Wolfe
Topics & Concepts
MedicinePost-hoc analysisType 2 diabetesAspirinPlaceboDiabetes mellitusRandomized controlled trialPost hocLow dose aspirinPhysical therapyMEDLINEInternal medicineGerontologyAlternative medicineEndocrinologyPolitical sciencePathologyLawAntiplatelet Therapy and Cardiovascular DiseasesInflammatory mediators and NSAID effectsPharmaceutical Practices and Patient Outcomes